GENB (Generate Biomedicines) Other Current Liabilities: $16.43 Mil (As of Dec. 2025)


GENB Generate Biomedicines Inc GENB
6 GF Score
Price $16.92
! 2 Warning Signs
View Full Analysis

What is Generate Biomedicines Other Current Liabilities?

Generate Biomedicines GENB +2.18% 6 Other Current Liabilities is $16.43 Mil as of Dec. 2025. GuruFocus rates GENB with a GF Score™ of 6/100. The stock has 2 warning signs investors should review.

Generate Biomedicines's other current liabilities for the quarter that ended in Dec. 2025 was $16.43 Mil.

Generate Biomedicines's quarterly other current liabilities increased from . 20 ($0.00 Mil) to Dec. 2024 ($15.78 Mil) and increased from Dec. 2024 ($15.78 Mil) to Dec. 2025 ($16.43 Mil).

Generate Biomedicines's annual other current liabilities increased from . 20 ($0.00 Mil) to Dec. 2024 ($15.78 Mil) and increased from Dec. 2024 ($15.78 Mil) to Dec. 2025 ($16.43 Mil).

Generate Biomedicines Other Current Liabilities Related Terms

Generate Biomedicines Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Generate Biomedicines's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Generate Biomedicines Other Current Liabilities Chart

Generate Biomedicines Annual Data
Trend Dec24 Dec25
Other Current Liabilities
15.78 16.43

Generate Biomedicines Semi-Annual Data
Dec24 Dec25
Other Current Liabilities 15.78 16.43
GENB
6GF Score
Generate Biomedicines Inc GENB
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Generate Biomedicines Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $16.43 Mil mean?
Generate Biomedicines (GENB) has a Other Current Liabilities of $16.43 Mil as of Dec. 2025. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Generate Biomedicines.
Is Generate Biomedicines' Other Current Liabilities too high?
Generate Biomedicines' current Other Current Liabilities is $16.43 Mil. Overall, Generate Biomedicines has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Generate Biomedicines' Other Current Liabilities compare to PVLA and SLBT?
Generate Biomedicines' Other Current Liabilities of $16.43 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Generate Biomedicines. Generate Biomedicines's current Other Current Liabilities is $16.43 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Generate Biomedicines stock overvalued right now?
Generate Biomedicines (GENB) has a current Other Current Liabilities of $16.43 Mil. The current Other Current Liabilities is $16.43 Mil. Generate Biomedicines' overall GF Score™ is 6/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Generate Biomedicines (GENB), the current Other Current Liabilities is $16.43 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Generate Biomedicines Business Description

Address 101 South Street, Suite 900, Somerville, MA, USA, 02143
Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.
6GF Score

Get the complete analysis for GENB

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$16.92
Price